Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borlaug Infection Prevention Services (BIPS) is a healthcare technology company dedicated to reducing the incidence of healthcare-associated infections (HAIs) through advanced material science. The company provides a proprietary, long-lasting antimicrobial surface protection system designed to provide continuous disinfection in clinical and high-traffic environments. Their core technology creates a persistent barrier on surfaces that mechanically destroys pathogens, supplementing traditional chemical cleaning protocols. BIPS focuses on high-touch surfaces in hospitals, clinics, and long-term care facilities to enhance patient safety and operational efficiency. The company is led by descendants of Nobel Laureate Norman Borlaug, applying a legacy of scientific innovation to modern infection control challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borlaug Infection Prevention Services.